Sei sulla pagina 1di 2



Based on data from the World Health Organization (WHO, 2015) around 450
million people worldwide suffer from mental problems and mention that mental
disorders are serious problems. Patients with schizophrenia generally experience serious
impairments in multiple domains of everyday life, including the ability to maintain social
relationships, sustain employment and live independently (Harvey, 2014). So that
recovery is needed and therapy is given to increase the quality of life (Fervaha, Foussias,
Agid, and Remington, 2012).
A holistic approach to this complex syndrome that combines medication and
evidence-based psychosocial treatments can improve outcomes, especially if the
treatment plan engages the patient as a collaborator(Iris E C Sommer, Andreas Meyer-
Lindenberg, Robin Murray, Tyrone Cannon, et al, 2015).Lara Guedes de Pinho, Anabela
Pereira, Cláudia Chaves (2017), believe that establishing a therapeutic relationship with
the person with schizophrenia is a constant challenge and must accompany the various
stages of the disease in cooperation with the family and the community. Before
committing to this relationship, the nurses must have a vast knowledge about themselves
and the disease, knowing their limits and eliminating any existing stigma in relation to
the patient.The role of the pharmacist in a pharmaceutical care model needs to be
enlarged to improve efficiency and safety of drug therapy, to guard compliance to
medication, to improve patients’ quality of life and to ameliorate patient satisfaction
(Rijcken, 2003). Pharmacists need to be better educated on the importance of their roles
in optimizing care for schizophrenic patients (Hadiza Yusuf, Hadiza Usman Ma'aji,
Shafiu Mohammed, Samirah Nndwan Abdu-Aguye, et al, 2018).
Previous research conducted by Setyawan (2017) states that the attitude of health
cadres on how to treat post-treatment patients in the Jatinom Klaten health center
working area about post-pasung patient care before getting a health education is negative
big. Holly Feret, Laura Conway, Jehannine C. Austin (2011), states that many groups of
health care professionals have negative attitudes towards affected individuals, which can
interfere with health care relationships, and researchers investigate investigators' genetic
relationships in patients with schizophrenia. Research undertaken by Ristic et al (2016)
attempted to examine the attitudes of medical and pharmaceutical students towards
schizophrenia patients and obtained results that there were statistically significant
differences in attitudes toward people with schizophrenia between medical and
pharmaceutical second and fifth years. student.
While in Indonesia alone there has been no research that tries to explore the
attitudes of pharmaceutical students and nurses towards schizophrenia patients in
Indonesia. Thus, the aim of our study is to study the attitudes of nursing and
pharmaceutical students towards patients with schizophrenia in Indonesia.
Hadiza Yusuf, Hadiza Usman Ma'aji, Shafiu Mohammed, Samirah Nndwan Abdu-Aguye, et
al. (2018). The Roles of Pharmacists in Optimizing Care for Schizophrenic Patients at
a Tertiary Health Facility in Maiduguri, North-Eastern Nigeria. ResearchGate, 132-
Harvey, P. (2014). Assessing disability in schizophrenia: tools and contributors. J.Clin.
Holly Feret, Laura Conway, Jehannine C. Austin. (2011). Generic counselor's attitudes
toward individuals with schizophrenia: Desire for social distance and endorsement of
stereotypes. Elsevier, 69-73.
Iris E C Sommer, Andreas Meyer-Lindenberg, Robin Murray, Tyrone Cannon, et al. (2015).
Schizophrenia. ResearchGate, 1-23.
Lara Guedes de Pinho, Anabela Pereira, Cláudia Chaves. (2017). Nursing interventions in
schizophrenia: the. Nursing & Care Open Access Journal, 331-333.
Rijcken, C. Pharmacy data as a tool for assessing antipsychotic drug use. University of